Latest Affinity Asset Advisors, LLC Stock Portfolio
$807Million– No. of Holdings #73
Affinity Asset Advisors, LLC Performance:
2024 Q1: 14.29%YTD: 14.29%2023: 22.28%
Performance for 2024 Q1 is 14.29%, and YTD is 14.29%, and 2023 is 22.28%.
About Affinity Asset Advisors, LLC and 13F Hedge Fund Stock Holdings
Affinity Asset Advisors, LLC is a hedge fund based in NEW YORK, NY. On 29-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $237.6 Millions. In it's latest 13F Holdings report, Affinity Asset Advisors, LLC reported an equity portfolio of $807.8 Millions as of 31 Mar, 2024.
The top stock holdings of Affinity Asset Advisors, LLC are , XENE, MDGL. The fund has invested 4.9% of it's portfolio in APOGEE THERAPEUTICS INC and 4.5% of portfolio in XENON PHARMACEUTICALS INC.
The fund managers got completely rid off IMMUNOGEN INC (IMGN), CYMABAY THERAPEUTICS INC (CBAY) and LIANBIO (LIAN) stocks. They significantly reduced their stock positions in VIKING THERAPEUTICS INC (VKTX), ALKERMES PLC (ALKS) and CEREVEL THERAPEUTICS HLDNG I (CERE). Affinity Asset Advisors, LLC opened new stock positions in VERA THERAPEUTICS INC (VERA), BEIGENE LTD (BGNE) and GERON CORP (GERN). The fund showed a lot of confidence in some stocks as they added substantially to INARI MED INC (NARI), TERNS PHARMACEUTICALS INC (TERN) and MORPHIC HLDG INC (MORF).
The top stock holdings of Affinity Asset Advisors, LLC are , XENE, MDGL. The fund has invested 4.9% of it's portfolio in APOGEE THERAPEUTICS INC and 4.5% of portfolio in XENON PHARMACEUTICALS INC.
The fund managers got completely rid off IMMUNOGEN INC (IMGN), CYMABAY THERAPEUTICS INC (CBAY) and LIANBIO (LIAN) stocks. They significantly reduced their stock positions in VIKING THERAPEUTICS INC (VKTX), ALKERMES PLC (ALKS) and CEREVEL THERAPEUTICS HLDNG I (CERE). Affinity Asset Advisors, LLC opened new stock positions in VERA THERAPEUTICS INC (VERA), BEIGENE LTD (BGNE) and GERON CORP (GERN). The fund showed a lot of confidence in some stocks as they added substantially to INARI MED INC (NARI), TERNS PHARMACEUTICALS INC (TERN) and MORPHIC HLDG INC (MORF).
Affinity Asset Advisors, LLC Equity Portfolio Value
Last Reported on: 14 May, 2024
Affinity Asset Advisors, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Affinity Asset Advisors, LLC made a return of 14.29% in the last quarter. In trailing 12 months, it's portfolio return was 37.59%.
New Buys
| Ticker | $ Bought |
|---|---|
| vera therapeutics inc | 20,266,400 |
| beigene ltd | 12,846,300 |
| alnylam pharmaceuticals inc | 9,448,760 |
| geron corp | 8,250,000 |
| elevation oncology inc | 6,509,070 |
| perspective therapeutics inc | 6,069,000 |
| absci corporation | 5,822,000 |
| mineralys therapeutics inc | 4,233,950 |
New stocks bought by Affinity Asset Advisors, LLC
Additions
Additions to existing portfolio by Affinity Asset Advisors, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| viking therapeutics inc | -83.33 |
| alkermes plc | -78.96 |
| cerevel therapeutics hldng i | -60.00 |
| cytokinetics inc | -50.00 |
| tango therapeutics inc | -49.95 |
| astria therapeutics inc | -42.34 |
| bridgebio pharma inc | -37.5 |
| establishment labs hldgs inc | -27.9 |
Affinity Asset Advisors, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| lianbio | -16,895,200 |
| immunogen inc | -41,646,600 |
| cymabay therapeutics inc | -25,756,200 |
| adc therapeutics sa | -1,682,480 |
| allogene therapeutics inc | -1,284,000 |
| aravive inc | -42,863 |
| dynavax technologies corp | -4,194,000 |
| relay therapeutics inc | -3,303,000 |
Affinity Asset Advisors, LLC got rid off the above stocks
Sector Distribution
Affinity Asset Advisors, LLC has about 80.3% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 80.3 |
| Others | 19.7 |
Market Cap. Distribution
Affinity Asset Advisors, LLC has about 5.9% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 46.4 |
| SMALL-CAP | 20.6 |
| UNALLOCATED | 19.7 |
| MICRO-CAP | 6.7 |
| LARGE-CAP | 3.7 |
| MEGA-CAP | 2.2 |
Stocks belong to which Index?
About 54.3% of the stocks held by Affinity Asset Advisors, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 54.3 |
| Others | 45.4 |
Affinity Asset Advisors, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Affinity Asset Advisors, LLC
Affinity Asset Advisors, LLC has 73 stocks in it's portfolio. About 31.2% of the portfolio is in top 10 stocks. IMVT proved to be the most loss making stock for the portfolio. ATXS was the most profitable stock for Affinity Asset Advisors, LLC last quarter.
Last Reported on: 14 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABSI | absci corporation | 0.72 | 1,025,000 | 5,822,000 | new | |||
| ACLX | arcellx inc | 2.58 | 300,000 | 20,865,000 | reduced | -11.76 | ||
| ADCT | adc therapeutics sa | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AGLE | spyre therapeutics inc | 1.93 | 410,000 | 15,551,300 | reduced | -20.78 | ||
| ALKS | alkermes plc | 0.25 | 75,000 | 2,030,250 | reduced | -78.96 | ||
| ALLO | allogene therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALNY | alnylam pharmaceuticals inc | 1.17 | 10,000,000 | 9,448,760 | new | |||
| APLS | apellis pharmaceuticals inc | 1.20 | 165,000 | 9,698,700 | added | 120 | ||
| ARAV | aravive inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ARGX | argenx se | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ARWR | arrowhead pharmaceuticals in | 0.42 | 120,000 | 3,432,000 | new | |||
| ARYD | arya sciences acqu corp iv | 0.19 | 133,500 | 1,504,540 | new | |||
| ASND | ascendis pharma a/s | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ATXS | astria therapeutics inc | 1.47 | 845,606 | 11,901,900 | reduced | -42.34 | ||
| AUTL | autolus therapeutics plc | 2.67 | 3,375,000 | 21,532,500 | added | 117 | ||
| AVRO | avrobio inc | 0.11 | 700,000 | 896,000 | added | 40.00 | ||
| AVTX | avalo therapeutics inc | 0.03 | 10,000 | 217,500 | new | |||
| AXSM | axsome therapeutics inc | 1.38 | 139,758 | 11,152,700 | added | 179 | ||
| AZN | astrazeneca plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BBIO | bridgebio pharma inc | 2.27 | 17,000,000 | 18,298,300 | unchanged | 0.00 | ||